This trial is active not recruiting!
Search for a recruiting clinical trial for your condition
You can access this
clinical trial
if you have
Breast Cancer, Musculoskeletal Complications or Pain
and you are a woman who is
under 120
years old
Phase
3
This is a trial in the final phase before the treatment is released on the market.
Show me locations

The purpose

RATIONALE: Duloxetine hydrochloride may lessen muscle, bone, and joint pain caused by hormone therapy. It is not yet known whether duloxetine hydrochloride is more effective than a placebo in treating patients with muscle, bone, and joint pain caused by hormone therapy. PURPOSE: This randomized phase III trial studies how well duloxetine hydrochloride works compared to a placebo in treating muscle, bone, and joint pain in patients with early-stage breast cancer receiving hormone therapy.

Provided treatments

  • Drug: duloxetine hydrochloride
  • Other: placebo
Tris trial is registered with FDA with number: NCT01598298. The sponsor of the trial is Southwest Oncology Group and it is looking for 299 volunteers for the current phase.
Official trial title:
A Randomized Placebo-Controlled Phase III Study of Duloxetine for Treatment of Aromatase Inhibitor-Associated Musculoskeletal Symptoms in Women With Early Stage Breast Cancer